TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
OCUL

Ocular Therapeutix Inc

Healthcare · Biotechnology

10.00$ +0.0% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

Ocular Therapeutix Inc (OCUL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 13 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement OCUL
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
15 15 15 16 15 17 11 13 15 13 11 13 52
1.4 1.4 1.3 1.5 1.6 1.2 1.3 1.9 1.8 1.6 1.3 2.0 6.7
14 13 13 15 14 16 9.4 12 13 12 9.5 11 45
15 16 21 29 37 41 43 51 52 51 66 54 224
17 44 23 20 12 24 29 27 16 18 20 22 76
33 33 45 59 60 66 73 79 81 81 103 94 359
-19 -20 -32 -44 -46 -51 -64 -68 -69 -70 -93 -82 -314
3.4 4.2 4.1 3.2 3.2 3.1 3.0 3.0 3.0 2.8 2.8 2.8 11
-0.5 -29 -65 -44 -36 -48 -64 -68 -69 -65 -89 -79 -301
-0.9 -7.2 -0.9
-0.5 -29 -65 -44 -36 -48 -64 -68 -69 -65 -89 -79 -301
3.8 -24 -60 -40 -32 -44 -60 -64 -65 -61 -85 -74 -285

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?